APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insulin Like Growth Factor 1 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Insulin Like Growth Factor 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174003610319 December 2025192 pages

Choose your research edition.

Industry ResearchInsulin Like Growth Factor 1 Receptor Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Like Growth Factor 1 Receptor Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Insulin Like Growth Factor 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Like Growth Factor 1 Receptor Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Like Growth Factor 1 Receptor Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Insulin Like Growth Factor 1 Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Like Growth Factor 1 Receptor include Novartis AG, Merck & Co., Inc., Eli Lilly and Company, AstraZeneca Plc, ProteoThera, Inc., PharmAbcine, Inc., Merrimack Pharmaceuticals, Inc., Insmed Incorporated and Immunomedics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Insulin Like Growth Factor 1 Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insulin Like Growth Factor 1 Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin Like Growth Factor 1 Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin Like Growth Factor 1 Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin Like Growth Factor 1 Receptor Segment by Company

Novartis AG

Merck & Co., Inc.

Eli Lilly and Company

AstraZeneca Plc

ProteoThera, Inc.

PharmAbcine, Inc.

Merrimack Pharmaceuticals, Inc.

Insmed Incorporated

Immunomedics, Inc.

Genmab A/S

F. Hoffmann-La Roche Ltd.

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

Axelar AB

Astellas Pharma Inc.

Insulin Like Growth Factor 1 Receptor Segment by Type

CT-707

BI-893923

ATL-1101

1R-E1

Others

Insulin Like Growth Factor 1 Receptor Segment by Application

Hospital

Clinic

Others

Insulin Like Growth Factor 1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Like Growth Factor 1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Like Growth Factor 1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Like Growth Factor 1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin Like Growth Factor 1 Receptor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Like Growth Factor 1 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Insulin Like Growth Factor 1 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Insulin Like Growth Factor 1 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Insulin Like Growth Factor 1 Receptor Industry Trends Table 2. Insulin Like Growth Factor 1 Receptor Industry Drivers Table 3. Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges Table 4. Insulin Like Growth Factor 1 Receptor Industry Restraints Table 5. Global Insulin Like Growth Factor 1 Receptor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Insulin Like Growth Factor 1 Receptor Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturers Table 9. Global Insulin Like Growth Factor 1 Receptor Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Insulin Like Growth Factor 1 Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Insulin Like Growth Factor 1 Receptor Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Insulin Like Growth Factor 1 Receptor Manufacturers, Product Type & Application Table 13. Global Insulin Like Growth Factor 1 Receptor Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin Like Growth Factor 1 Receptor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of CT-707 Table 17. Major Manufacturers of BI-893923 Table 18. Major Manufacturers of ATL-1101 Table 19. Major Manufacturers of 1R-E1 Table 20. Major Manufacturers of Others Table 21. Global Insulin Like Growth Factor 1 Receptor Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 23. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 24. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2026) Table 25. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2027-2032) Table 26. Global Insulin Like Growth Factor 1 Receptor Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2026) & (W Units) Table 28. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2027-2032) & (W Units) Table 29. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2026) Table 30. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global Insulin Like Growth Factor 1 Receptor Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 36. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 37. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2026) Table 38. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2027-2032) Table 39. Global Insulin Like Growth Factor 1 Receptor Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 40. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2026) & (W Units) Table 41. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2027-2032) & (W Units) Table 42. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2026) Table 43. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2027-2032) Table 44. Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2026) & (W Units) Table 46. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2021-2026) Table 47. Global Insulin Like Growth Factor 1 Receptor Sales Forecasted by Region (2027-2032) & (W Units) Table 48. Global Insulin Like Growth Factor 1 Receptor Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Insulin Like Growth Factor 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 51. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 52. Europe Insulin Like Growth Factor 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 54. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 55. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 57. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 58. South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 60. South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 61. Global Insulin Like Growth Factor 1 Receptor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2021-2026) Table 65. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2027-2032) Table 66. Novartis AG Company Information Table 67. Novartis AG Business Overview Table 68. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio Table 70. Novartis AG Recent Development Table 71. Merck & Co., Inc. Company Information Table 72. Merck & Co., Inc. Business Overview Table 73. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 75. Merck & Co., Inc. Recent Development Table 76. Eli Lilly and Company Company Information Table 77. Eli Lilly and Company Business Overview Table 78. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 80. Eli Lilly and Company Recent Development Table 81. AstraZeneca Plc Company Information Table 82. AstraZeneca Plc Business Overview Table 83. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio Table 85. AstraZeneca Plc Recent Development Table 86. ProteoThera, Inc. Company Information Table 87. ProteoThera, Inc. Business Overview Table 88. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 90. ProteoThera, Inc. Recent Development Table 91. PharmAbcine, Inc. Company Information Table 92. PharmAbcine, Inc. Business Overview Table 93. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 95. PharmAbcine, Inc. Recent Development Table 96. Merrimack Pharmaceuticals, Inc. Company Information Table 97. Merrimack Pharmaceuticals, Inc. Business Overview Table 98. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 100. Merrimack Pharmaceuticals, Inc. Recent Development Table 101. Insmed Incorporated Company Information Table 102. Insmed Incorporated Business Overview Table 103. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio Table 105. Insmed Incorporated Recent Development Table 106. Immunomedics, Inc. Company Information Table 107. Immunomedics, Inc. Business Overview Table 108. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 110. Immunomedics, Inc. Recent Development Table 111. Genmab A/S Company Information Table 112. Genmab A/S Business Overview Table 113. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio Table 115. Genmab A/S Recent Development Table 116. F. Hoffmann-La Roche Ltd. Company Information Table 117. F. Hoffmann-La Roche Ltd. Business Overview Table 118. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 120. F. Hoffmann-La Roche Ltd. Recent Development Table 121. Bristol-Myers Squibb Company Company Information Table 122. Bristol-Myers Squibb Company Business Overview Table 123. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 125. Bristol-Myers Squibb Company Recent Development Table 126. Boehringer Ingelheim GmbH Company Information Table 127. Boehringer Ingelheim GmbH Business Overview Table 128. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio Table 130. Boehringer Ingelheim GmbH Recent Development Table 131. Axelar AB Company Information Table 132. Axelar AB Business Overview Table 133. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio Table 135. Axelar AB Recent Development Table 136. Astellas Pharma Inc. Company Information Table 137. Astellas Pharma Inc. Business Overview Table 138. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 140. Astellas Pharma Inc. Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Insulin Like Growth Factor 1 Receptor Distributors List Table 144. Insulin Like Growth Factor 1 Receptor Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Insulin Like Growth Factor 1 Receptor Product Image Figure 2. Global Insulin Like Growth Factor 1 Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Like Growth Factor 1 Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Like Growth Factor 1 Receptor Sales (2021-2032) & (W Units) Figure 5. Global Insulin Like Growth Factor 1 Receptor Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Insulin Like Growth Factor 1 Receptor Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. CT-707 Image Figure 9. BI-893923 Image Figure 10. ATL-1101 Image Figure 11. 1R-E1 Image Figure 12. Others Image Figure 13. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Insulin Like Growth Factor 1 Receptor Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2032) Figure 16. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Insulin Like Growth Factor 1 Receptor Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2032) Figure 25. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2032) Figure 28. North America Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 29. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 30. U.S. Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Canada Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Mexico Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 35. Germany Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 36. France Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 37. U.K. Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Italy Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Netherlands Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 42. China Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Japan Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South Korea Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Southeast Asia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 46. India Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Australia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 50. Brazil Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South Africa Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Turkey Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Argentina Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 55. UAE Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Egypt Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Chile Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Global Insulin Like Growth Factor 1 Receptor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 61. North America Insulin Like Growth Factor 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 63. Europe Insulin Like Growth Factor 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Insulin Like Growth Factor 1 Receptor Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Insulin Like Growth Factor 1 Receptor Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • CT-707
  • BI-893923
  • ATL-1101
  • 1R-E1
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca Plc
  • ProteoThera, Inc.
  • PharmAbcine, Inc.
  • Merrimack Pharmaceuticals, Inc.
  • Insmed Incorporated
  • Immunomedics, Inc.
  • Genmab A/S
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Axelar AB
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Insulin Like Growth Factor 1 Receptor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Insulin Like Growth Factor 1 Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Insulin Like Growth Factor 1 Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Insulin Like Growth Factor 1 Receptor Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Insulin Like Growth Factor 1 Receptor Market Dynamics
  1. 2.1 Insulin Like Growth Factor 1 Receptor Industry Trends
  2. 2.2 Insulin Like Growth Factor 1 Receptor Industry Drivers
  3. 2.3 Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges
  4. 2.4 Insulin Like Growth Factor 1 Receptor Industry Restraints
3 Insulin Like Growth Factor 1 Receptor Market by Manufacturers
  1. 3.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Insulin Like Growth Factor 1 Receptor Sales by Manufacturers (2021-2026)
  3. 3.3 Global Insulin Like Growth Factor 1 Receptor Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Insulin Like Growth Factor 1 Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Like Growth Factor 1 Receptor Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Insulin Like Growth Factor 1 Receptor Manufacturers, Product Type & Application
  7. 3.7 Global Insulin Like Growth Factor 1 Receptor Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Like Growth Factor 1 Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Like Growth Factor 1 Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Like Growth Factor 1 Receptor Tier 1, Tier 2, and Tier 3
4 Insulin Like Growth Factor 1 Receptor Market by Type
  1. 4.1 Insulin Like Growth Factor 1 Receptor Type Introduction
  2. 4.1.1 CT-707
  3. 4.1.2 BI-893923
  4. 4.1.3 ATL-1101
  5. 4.1.4 1R-E1
  6. 4.1.5 Others
  7. 4.2 Global Insulin Like Growth Factor 1 Receptor Sales by Type
  8. 4.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032)
  10. 4.2.3 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2032)
  11. 4.3 Global Insulin Like Growth Factor 1 Receptor Revenue by Type
  12. 4.3.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2032)
  14. 4.3.3 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2032)
5 Insulin Like Growth Factor 1 Receptor Market by Application
  1. 5.1 Insulin Like Growth Factor 1 Receptor Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Insulin Like Growth Factor 1 Receptor Sales by Application
  6. 5.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032)
  8. 5.2.3 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2032)
  9. 5.3 Global Insulin Like Growth Factor 1 Receptor Revenue by Application
  10. 5.3.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2032)
  12. 5.3.3 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2032)
6 Global Insulin Like Growth Factor 1 Receptor Sales by Region
  1. 6.1 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2026)
  4. 6.2.2 Global Insulin Like Growth Factor 1 Receptor Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Insulin Like Growth Factor 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Insulin Like Growth Factor 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Insulin Like Growth Factor 1 Receptor Revenue by Region
  1. 7.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Region
  2. 7.1.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2021-2026)
  4. 7.1.3 Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2027-2032)
  5. 7.1.4 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Insulin Like Growth Factor 1 Receptor Revenue (2021-2032)
  8. 7.2.2 North America Insulin Like Growth Factor 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Insulin Like Growth Factor 1 Receptor Revenue (2021-2032)
  11. 7.3.2 Europe Insulin Like Growth Factor 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Eli Lilly and Company
  14. 8.3.1 Eli Lilly and Company Company Information
  15. 8.3.2 Eli Lilly and Company Business Overview
  16. 8.3.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  18. 8.3.5 Eli Lilly and Company Recent Developments
  19. 8.4 AstraZeneca Plc
  20. 8.4.1 AstraZeneca Plc Company Information
  21. 8.4.2 AstraZeneca Plc Business Overview
  22. 8.4.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio
  24. 8.4.5 AstraZeneca Plc Recent Developments
  25. 8.5 ProteoThera, Inc.
  26. 8.5.1 ProteoThera, Inc. Company Information
  27. 8.5.2 ProteoThera, Inc. Business Overview
  28. 8.5.3 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  30. 8.5.5 ProteoThera, Inc. Recent Developments
  31. 8.6 PharmAbcine, Inc.
  32. 8.6.1 PharmAbcine, Inc. Company Information
  33. 8.6.2 PharmAbcine, Inc. Business Overview
  34. 8.6.3 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  36. 8.6.5 PharmAbcine, Inc. Recent Developments
  37. 8.7 Merrimack Pharmaceuticals, Inc.
  38. 8.7.1 Merrimack Pharmaceuticals, Inc. Company Information
  39. 8.7.2 Merrimack Pharmaceuticals, Inc. Business Overview
  40. 8.7.3 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  42. 8.7.5 Merrimack Pharmaceuticals, Inc. Recent Developments
  43. 8.8 Insmed Incorporated
  44. 8.8.1 Insmed Incorporated Company Information
  45. 8.8.2 Insmed Incorporated Business Overview
  46. 8.8.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio
  48. 8.8.5 Insmed Incorporated Recent Developments
  49. 8.9 Immunomedics, Inc.
  50. 8.9.1 Immunomedics, Inc. Company Information
  51. 8.9.2 Immunomedics, Inc. Business Overview
  52. 8.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  54. 8.9.5 Immunomedics, Inc. Recent Developments
  55. 8.10 Genmab A/S
  56. 8.10.1 Genmab A/S Company Information
  57. 8.10.2 Genmab A/S Business Overview
  58. 8.10.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio
  60. 8.10.5 Genmab A/S Recent Developments
  61. 8.11 F. Hoffmann-La Roche Ltd.
  62. 8.11.1 F. Hoffmann-La Roche Ltd. Company Information
  63. 8.11.2 F. Hoffmann-La Roche Ltd. Business Overview
  64. 8.11.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio
  66. 8.11.5 F. Hoffmann-La Roche Ltd. Recent Developments
  67. 8.12 Bristol-Myers Squibb Company
  68. 8.12.1 Bristol-Myers Squibb Company Company Information
  69. 8.12.2 Bristol-Myers Squibb Company Business Overview
  70. 8.12.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  72. 8.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 8.13 Boehringer Ingelheim GmbH
  74. 8.13.1 Boehringer Ingelheim GmbH Company Information
  75. 8.13.2 Boehringer Ingelheim GmbH Business Overview
  76. 8.13.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio
  78. 8.13.5 Boehringer Ingelheim GmbH Recent Developments
  79. 8.14 Axelar AB
  80. 8.14.1 Axelar AB Company Information
  81. 8.14.2 Axelar AB Business Overview
  82. 8.14.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio
  84. 8.14.5 Axelar AB Recent Developments
  85. 8.15 Astellas Pharma Inc.
  86. 8.15.1 Astellas Pharma Inc. Company Information
  87. 8.15.2 Astellas Pharma Inc. Business Overview
  88. 8.15.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  90. 8.15.5 Astellas Pharma Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin Like Growth Factor 1 Receptor Value Chain Analysis
  2. 9.1.1 Insulin Like Growth Factor 1 Receptor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin Like Growth Factor 1 Receptor Production Mode & Process
  6. 9.2 Insulin Like Growth Factor 1 Receptor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin Like Growth Factor 1 Receptor Distributors
  9. 9.2.3 Insulin Like Growth Factor 1 Receptor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst